Graft versus host disease and Hair loss

Summary:

Hair loss is found among people with Graft versus host disease, especially for people who are female, 10-19 old.

The study analyzes which people have Hair loss with Graft versus host disease. It is created by eHealthMe based on reports of 30 people who have Graft versus host disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Graft versus host disease?

Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body) is found to be associated with 498 drugs and 642 conditions by eHealthMe. Check the latest studies of Graft versus host disease.

What is Hair loss?

Hair loss is found to be associated with 2,411 drugs and 3,513 conditions by eHealthMe. Check the latest studies of Hair loss.

On Jul, 20, 2026

30 people who have Graft Versus Host Disease and Hair Loss are studied.

Would you have Hair loss when you have Graft versus host disease?

Gender of people who have Graft Versus Host Disease and experienced Hair Loss *:

female: 55.56 %
male: 44.44 %

Age of people who have Graft Versus Host Disease and experienced Hair Loss *:

Common co-existing conditions for these people *:

High Blood Pressure: 6 people, 20.00%
Stress And Anxiety: 4 people, 13.33%
Pain: 4 people, 13.33%
Abnormal Behavior: 3 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.67%
Diabetes: 2 people, 6.67%
Insomnia (sleeplessness): 2 people, 6.67%
Sleep Disorder: 2 people, 6.67%
Depression: 2 people, 6.67%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 3.33%

Common drugs taken by these people *:

Jakafi: 12 people, 40.00%
Triamcinolone: 4 people, 13.33%
Methylprednisolone: 4 people, 13.33%
Restasis: 4 people, 13.33%
Zyvox: 3 people, 10.00%
Bactrim: 3 people, 10.00%
Gabapentin: 3 people, 10.00%
Hydrocodone Bitartrate And Acetaminophen: 3 people, 10.00%
Lorazepam: 3 people, 10.00%
Naloxone: 3 people, 10.00%

Common symptoms for these people *:

Acute Kidney Failure: 6 people, 20.00%
Rash Macular (small, flat red spots): 5 people, 16.67%
Weight Increased: 4 people, 13.33%
Diarrhea: 4 people, 13.33%
Fatigue (feeling of tiredness): 4 people, 13.33%
Joint Pain: 4 people, 13.33%
Bone Pain: 3 people, 10.00%
Chills (felling of cold): 3 people, 10.00%
Cushingoid (obesity and weakening of the muscles): 3 people, 10.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hair loss?

- Check whether Hair loss is associated with a drug or a condition

Related publications that referenced our studies

Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .

Related studies:

Treatments, associated drugs and conditions:

Graft versus host disease (17,483 reports)
Hair loss (271,201 reports)

All the drugs that are associated with Hair loss:

Hair loss (2,411 drugs)

All the conditions that are associated with Hair loss:

Hair loss (3,513 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hair loss and Graft versus host disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.